Nifty

:

22795.90

Sensex

:

75311.06

-117.25 (-0.51%)
-424.90 (-0.56%)

Login

Nifty
Sensex

:
:

22795.90
75311.06

-117.25 (-0.51%)
-424.90 (-0.56%)

Sakar Healthcare Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: Not Listed | NSE: SAKAR

Watchlist

NSE BSE

278.70

06-Feb-2025

Open
High
Low
Previous Close

280.65
283.55
272.60
280.05

Volume
Traded Value (lacs)
52 Week High
52 Week Low

5975
16.66
418.00
213.20

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

518.79
34.91
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

592.42
N/A
1.87

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

15.91
13.07
6.14

EBITDA CAGR (%)

10 Years
5 Years
3 Years

17.17
14.45
5.52

PAT CAGR (%)

10 Years
5 Years
3 Years

20.29
3.94
-8.39

P:E (Median)

8 Years
5 Years
3 Years

-
-
48.23

P:BV (Average)

8 Years
5 Years
3 Years

-
-
2.77

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
16.77

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 43.42 37.23 16.63% 42.78 34.08 25.53% 41.15 38.99 5.54% 43.06 40.65 5.93%
Expenses 31.66 28.22 12.19% 31.28 24.72 26.54% 30.45 29.96 1.64% 32.09 32.87 -2.37%
EBITDA 11.76 9.01 30.52% 11.50 9.36 22.86% 10.70 9.03 18.49% 10.97 7.78 41.00%
EBIDTM 27.08% 24.20% 26.89% 27.46% 26.00% 23.15% 25.47% 19.15%
Other Income 0.30 0.23 30.43% 0.37 0.66 -43.94% 0.46 1.52 -69.74% 0.77 1.82 -57.69%
Interest 1.30 1.79 -27.37% 1.64 1.65 -0.61% 1.40 2.08 -32.69% 2.08 2.15 -3.26%
Depreciation 5.23 4.45 17.53% 5.12 4.22 21.33% 5.06 4.52 11.95% 4.87 3.55 37.18%
PBT 5.48 3.00 82.67% 5.11 4.15 23.13% 4.70 3.95 18.99% 4.80 3.89 23.39%
Tax 0.94 0.93 1.08% 0.32 0.52 -38.46% 2.29 1.11 106.31% 1.67 -0.03 -
PAT 4.53 2.07 118.84% 4.80 3.64 31.87% 2.41 2.84 -15.14% 3.12 3.92 -20.41%
PATM 10.44% 5.57% 11.21% 10.67% 5.86% 7.29% 7.25% 9.65%
EPS 2.07 0.95 117.89% 2.19 1.66 31.93% 1.10 1.30 -15.38% 1.43 1.79 -20.11%

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 43.42 37.23 16.63% 42.78 34.08 25.53% 41.15 38.99 5.54% 43.06 40.65 5.93%
Expenses 31.66 28.22 12.19% 31.28 24.72 26.54% 30.45 29.96 1.64% 32.09 32.87 -2.37%
EBITDA 11.76 9.01 30.52% 11.50 9.36 22.86% 10.70 9.03 18.49% 10.97 7.78 41.00%
EBIDTM 27.08% 24.20% 26.89% 27.46% 26.00% 23.15% 25.47% 19.15%
Other Income 0.30 0.23 30.43% 0.37 0.66 -43.94% 0.46 1.52 -69.74% 0.77 1.82 -57.69%
Interest 1.30 1.79 -27.37% 1.64 1.65 -0.61% 1.40 2.08 -32.69% 2.08 2.15 -3.26%
Depreciation 5.23 4.45 17.53% 5.12 4.22 21.33% 5.06 4.52 11.95% 4.87 3.55 37.18%
PBT 5.48 3.00 82.67% 5.11 4.15 23.13% 4.70 3.95 18.99% 4.80 3.89 23.39%
Tax 0.94 0.93 1.08% 0.32 0.52 -38.46% 2.29 1.11 106.31% 1.67 -0.03 -
PAT 4.53 2.07 118.84% 4.80 3.64 31.87% 2.41 2.84 -15.14% 3.12 3.92 -20.41%
PATM 10.44% 5.57% 11.21% 10.67% 5.86% 7.29% 7.25% 9.65%
EPS 2.07 0.95 117.89% 2.21 1.70 30.00% 1.11 1.49 -25.50% 1.43 2.06 -30.58%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 170.41 153.35 133.36 128.23 94.74 82.98 68.25 53.08 44.17 41.23 35.03 Net Sales Growth 12.89% 14.99% 4.00% 35.35% 14.17% 21.58% 28.58% 20.17% 7.13% 17.70% Cost Of Goods Sold 92.52 83.67 73.54 74.42 51.11 43.05 35.41 28.00 22.29 21.97 17.33 Gross Profit 77.89 69.67 59.81 53.80 43.63 39.93 32.84 25.08 21.89 19.26 17.69 GP Margin 45.71% 45.43% 44.85% 41.96% 46.05% 48.12% 48.12% 47.25% 49.56% 46.71% 50.50% Total Expenditure 125.48 114.96 100.09 98.81 72.12 63.43 51.39 40.50 34.01 32.88 27.16 Power & Fuel Cost - 4.25 2.90 3.01 2.26 3.31 3.23 2.43 2.43 3.23 3.27 % Of Sales - 2.77% 2.17% 2.35% 2.39% 3.99% 4.73% 4.58% 5.50% 7.83% 9.33% Employee Cost - 18.82 15.81 14.26 12.74 11.61 8.45 6.55 5.64 4.49 3.80 % Of Sales - 12.27% 11.86% 11.12% 13.45% 13.99% 12.38% 12.34% 12.77% 10.89% 10.85% Manufacturing Exp. - 1.34 0.81 1.24 1.20 1.64 1.02 0.76 0.62 0.88 0.74 % Of Sales - 0.87% 0.61% 0.97% 1.27% 1.98% 1.49% 1.43% 1.40% 2.13% 2.11% General & Admin Exp. - 4.22 3.65 3.36 2.86 2.68 2.13 2.01 2.40 1.60 1.89 % Of Sales - 2.75% 2.74% 2.62% 3.02% 3.23% 3.12% 3.79% 5.43% 3.88% 5.40% Selling & Distn. Exp. - 2.17 3.06 2.37 1.33 1.10 1.13 0.69 0.63 0.63 0.12 % Of Sales - 1.42% 2.29% 1.85% 1.40% 1.33% 1.66% 1.30% 1.43% 1.53% 0.34% Miscellaneous Exp. - 0.49 0.32 0.15 0.63 0.04 0.02 0.06 0.00 0.09 0.12 % Of Sales - 0.32% 0.24% 0.12% 0.66% 0.05% 0.03% 0.11% 0% 0.22% 0% EBITDA 44.93 38.39 33.27 29.42 22.62 19.55 16.86 12.58 10.16 8.35 7.87 EBITDA Margin 26.37% 25.03% 24.95% 22.94% 23.88% 23.56% 24.70% 23.70% 23.00% 20.25% 22.47% Other Income 1.90 3.18 4.67 2.17 1.18 2.02 0.68 0.53 0.73 0.21 0.03 Interest 6.42 7.62 5.96 2.91 2.49 2.26 2.27 2.59 2.69 2.94 2.99 Depreciation 20.28 18.05 14.99 9.67 8.06 7.08 6.04 4.41 3.39 2.73 2.50 PBT 20.09 15.90 16.99 19.01 13.24 12.23 9.23 6.11 4.82 2.88 2.42 Tax 5.22 4.23 4.23 3.77 2.55 2.60 2.54 2.29 1.44 0.55 0.58 Tax Rate 25.98% 26.60% 24.90% 19.83% 19.26% 21.26% 27.52% 37.48% 29.88% 19.10% 23.97% PAT 14.86 11.67 12.76 15.24 10.69 9.62 6.69 3.81 3.38 2.33 1.84 PAT before Minority Interest 14.86 11.67 12.76 15.24 10.69 9.62 6.69 3.81 3.38 2.33 1.84 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 8.72% 7.61% 9.57% 11.88% 11.28% 11.59% 9.80% 7.18% 7.65% 5.65% 5.25% PAT Growth 19.17% -8.54% -16.27% 42.56% 11.12% 43.80% 75.59% 12.72% 45.06% 26.63% EPS 6.79 5.33 5.83 6.96 4.88 4.39 3.05 1.74 1.54 1.06 0.84

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Net Sales 170.41 153.35 133.36 128.23 94.74 82.98 Net Sales Growth 12.89% 14.99% 4.00% 35.35% 14.17% Cost Of Goods Sold 92.52 83.67 73.54 74.42 51.11 43.05 Gross Profit 77.89 69.67 59.81 53.80 43.63 39.93 GP Margin 45.71% 45.43% 44.85% 41.96% 46.05% 48.12% Total Expenditure 125.48 114.96 100.09 98.89 72.13 63.43 Power & Fuel Cost - 4.25 2.90 3.01 2.26 3.31 % Of Sales - 2.77% 2.17% 2.35% 2.39% 3.99% Employee Cost - 18.82 15.81 14.26 12.74 11.61 % Of Sales - 12.27% 11.86% 11.12% 13.45% 13.99% Manufacturing Exp. - 1.34 0.81 1.24 1.20 1.64 % Of Sales - 0.87% 0.61% 0.97% 1.27% 1.98% General & Admin Exp. - 4.22 3.65 3.43 2.87 2.68 % Of Sales - 2.75% 2.74% 2.67% 3.03% 3.23% Selling & Distn. Exp. - 2.17 3.06 2.38 1.33 1.10 % Of Sales - 1.42% 2.29% 1.86% 1.40% 1.33% Miscellaneous Exp. - 0.49 0.32 0.15 0.61 0.04 % Of Sales - 0.32% 0.24% 0.12% 0.64% 0.05% EBITDA 44.93 38.39 33.27 29.34 22.61 19.55 EBITDA Margin 26.37% 25.03% 24.95% 22.88% 23.87% 23.56% Other Income 1.90 3.18 4.67 2.17 1.18 2.02 Interest 6.42 7.62 5.96 2.91 2.49 2.26 Depreciation 20.28 18.05 14.99 9.67 8.06 7.08 PBT 20.09 15.90 16.99 18.93 13.23 12.23 Tax 5.22 4.23 4.23 3.75 2.55 2.60 Tax Rate 25.98% 26.60% 24.90% 19.81% 19.27% 21.26% PAT 14.86 11.67 12.76 15.18 10.68 9.62 PAT before Minority Interest 14.86 11.67 12.76 15.18 10.68 9.62 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 8.72% 7.61% 9.57% 11.84% 11.27% 11.59% PAT Growth 19.17% -8.54% -15.94% 42.13% 11.02% EPS 6.79 5.33 5.83 6.93 4.88 4.39

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 262.42 173.43 127.54 98.46 81.32 71.73 51.49 35.50 17.16 14.83 Share Capital 21.75 19.04 17.12 15.62 14.96 14.96 12.21 10.96 8.00 8.00 Total Reserves 235.87 154.39 110.42 82.84 66.36 56.77 34.61 24.54 9.16 6.83 Non-Current Liabilities 67.27 108.50 93.54 46.07 19.57 11.76 16.82 22.36 21.75 25.11 Secured Loans 52.30 93.17 79.93 35.04 8.79 1.57 4.69 8.10 8.06 11.02 Unsecured Loans 2.65 5.05 5.07 3.41 3.68 3.64 5.15 7.81 7.36 7.76 Long Term Provisions 2.29 1.70 1.44 0.79 0.70 0.47 0.00 0.00 0.00 0.00 Current Liabilities 59.06 54.49 46.78 33.27 14.24 13.88 12.79 12.73 12.20 10.23 Trade Payables 27.45 26.09 30.50 19.78 5.44 3.99 4.41 3.10 3.98 0.96 Other Current Liabilities 16.30 13.58 8.57 8.82 4.98 5.12 5.84 3.96 3.99 2.92 Short Term Borrowings 13.88 13.02 4.52 1.69 2.26 2.73 1.37 5.32 3.91 5.97 Short Term Provisions 1.43 1.80 3.19 2.97 1.55 2.04 1.17 0.34 0.32 0.38 Total Liabilities 388.75 336.42 267.86 177.80 115.13 97.37 81.10 70.59 51.11 50.17 Net Block 314.29 266.64 204.65 69.10 65.69 63.54 53.33 48.93 37.25 36.18 Gross Block 370.69 304.99 235.50 90.28 78.81 69.58 76.47 67.66 52.59 48.79 Accumulated Depreciation 56.40 38.35 30.84 21.18 13.12 6.04 23.14 18.73 15.34 12.61 Non Current Assets 317.06 280.43 217.75 144.00 93.47 77.33 53.68 49.36 37.53 36.47 Capital Work in Progress 0.32 6.45 1.23 48.92 13.10 8.66 0.00 0.00 0.00 0.00 Non Current Investment 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 2.44 7.33 11.86 25.97 14.68 5.13 0.35 0.43 0.28 0.28 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 71.69 55.99 50.10 33.80 21.65 20.06 27.42 21.23 13.58 13.71 Current Investments 0.00 3.43 7.11 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 27.73 15.40 14.18 15.70 10.93 6.86 3.93 6.96 6.45 6.74 Sundry Debtors 20.91 22.08 14.18 12.37 8.23 9.50 10.82 5.35 2.98 2.01 Cash & Bank 0.46 0.09 0.03 0.08 0.30 0.37 0.36 0.45 0.23 0.93 Other Current Assets 22.58 0.46 0.22 0.09 2.19 3.33 12.31 8.47 3.92 4.03 Short Term Loans & Adv. 21.73 14.54 14.38 5.56 2.11 3.26 8.75 5.44 3.27 3.31 Net Current Assets 12.63 1.50 3.32 0.53 7.41 6.17 14.63 8.50 1.38 3.48 Total Assets 388.75 336.42 267.85 177.80 115.12 97.39 81.10 70.59 51.11 50.18

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Shareholder's Funds 262.33 173.35 127.45 98.45 81.32 Share Capital 21.75 19.04 17.12 15.62 14.96 Total Reserves 235.78 154.31 110.33 82.83 66.36 Non-Current Liabilities 67.27 108.50 93.54 46.07 19.57 Secured Loans 52.30 93.17 79.93 35.04 8.79 Unsecured Loans 2.65 5.05 5.07 3.41 3.68 Long Term Provisions 2.29 1.70 1.44 0.79 0.70 Current Liabilities 59.06 54.49 46.78 33.27 14.15 Trade Payables 27.45 26.09 30.50 19.78 5.44 Other Current Liabilities 16.30 13.58 8.57 8.82 4.98 Short Term Borrowings 13.88 13.02 4.52 1.69 2.18 Short Term Provisions 1.43 1.80 3.19 2.97 1.55 Total Liabilities 388.66 336.34 267.77 177.79 115.04 Net Block 314.29 266.64 204.65 69.10 65.69 Gross Block 370.69 304.99 235.50 90.28 78.81 Accumulated Depreciation 56.40 38.35 30.84 21.18 13.12 Non Current Assets 317.05 280.42 217.74 144.07 93.46 Capital Work in Progress 0.32 6.45 1.23 48.92 13.10 Non Current Investment 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 2.44 7.33 11.86 26.05 14.68 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 Current Assets 71.61 55.92 50.02 33.72 21.58 Current Investments 0.00 3.43 7.11 0.00 0.00 Inventories 27.73 15.40 14.18 15.70 10.93 Sundry Debtors 20.91 22.08 14.18 12.37 8.23 Cash & Bank 0.47 0.09 0.03 0.08 0.30 Other Current Assets 22.50 0.46 0.22 0.09 2.12 Short Term Loans & Adv. 21.65 14.46 14.30 5.48 2.04 Net Current Assets 12.55 1.42 3.25 0.45 7.42 Total Assets 388.66 336.34 267.76 177.79 115.04

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 24.47 33.34 35.79 14.58 18.79 16.14 5.26 9.19 9.19 4.18 PBT 15.90 16.88 19.01 13.24 12.23 9.23 6.11 2.86 2.88 2.42 Adjustment 24.90 20.14 12.50 8.90 9.19 8.09 6.46 5.46 5.46 5.46 Changes in Working Capital 101.03 0.60 4.09 -6.83 0.15 0.21 -6.14 1.41 1.39 -3.19 Cash after chg. in Working capital 141.83 37.61 35.60 15.31 21.56 17.54 6.43 9.74 9.74 4.69 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -117.36 -4.27 0.19 -0.73 -2.77 -1.40 -1.16 -0.55 -0.55 -0.51 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -51.54 -74.38 -90.40 -46.83 -22.34 -24.91 -8.28 -3.59 -3.59 -0.64 Net Fixed Assets -59.57 -74.71 -97.53 -47.29 -13.67 -1.77 -8.81 -15.07 -3.80 -0.67 Net Investments 3.43 3.68 -7.11 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 Others 4.60 -3.35 14.24 0.46 -8.66 -23.14 0.53 11.48 0.21 0.03 Cash from Financing Activity 27.44 41.10 54.56 32.03 3.48 8.77 -12.99 -6.30 -6.30 -2.69 Net Cash Inflow / Outflow 0.37 0.06 -0.05 -0.22 -0.07 0.00 -16.01 -0.70 -0.70 0.84 Opening Cash & Equivalents 0.09 0.03 0.08 0.30 0.37 0.36 0.45 0.93 0.93 0.09 Closing Cash & Equivalent 0.46 0.09 0.03 0.08 0.30 0.37 -15.55 0.23 0.23 0.93

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Cash From Operating Activity 24.47 33.34 35.70 14.58 18.86 PBT 15.90 16.88 18.93 13.23 12.23 Adjustment 24.90 20.14 12.50 8.90 9.19 Changes in Working Capital 101.03 0.60 4.09 -6.83 0.22 Cash after chg. in Working capital 141.83 37.61 35.52 15.30 21.64 Interest Paid 0.00 0.00 0.00 0.00 0.00 Tax Paid -117.36 -4.27 0.18 -0.73 -2.77 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -51.54 -74.38 -90.37 -46.83 -22.41 Net Fixed Assets -59.57 -74.71 -97.53 -47.29 Net Investments 3.43 3.68 -7.11 0.00 Others 4.60 -3.35 14.27 0.46 Cash from Financing Activity 27.44 41.10 54.62 32.03 3.48 Net Cash Inflow / Outflow 0.37 0.06 -0.05 -0.22 -0.06 Opening Cash & Equivalents 0.09 0.03 0.08 0.31 0.37 Closing Cash & Equivalent 0.47 0.09 0.03 0.08 0.31

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 118.44 91.09 74.50 63.04 54.35 47.95 38.34 32.39 21.45 18.53 ROA 3.22% 4.22% 6.84% 7.30% 9.06% 7.50% 5.03% 5.55% 4.60% 3.58% ROE 5.42% 8.48% 13.49% 11.89% 12.57% 11.29% 9.27% 12.83% 14.56% 13.20% ROCE 7.41% 8.95% 12.13% 13.16% 16.02% 15.45% 14.17% 16.11% 15.29% 13.89% Fixed Asset Turnover 0.45 0.49 0.79 1.12 1.12 0.93 0.74 0.73 0.81 0.72 Receivable days 51.16 49.62 37.80 39.70 39.01 54.34 55.58 34.38 22.05 22.17 Inventory Days 51.33 40.48 42.53 51.30 39.13 28.85 37.44 55.38 58.37 70.92 Payable days 116.77 140.43 123.30 90.05 39.98 27.49 32.33 35.98 26.35 28.28 Cash Conversion Cycle -14.29 -50.33 -42.97 0.95 38.16 55.69 60.69 53.79 54.07 64.81 Total Debt/Equity 0.31 0.69 0.73 0.43 0.21 0.16 0.31 0.60 1.13 1.67 Interest Cover 3.09 3.85 7.53 6.31 6.41 5.07 3.36 2.79 1.98 1.81

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Book Value (Rs.) 118.41 91.04 74.45 63.04 54.35 ROA 3.22% 4.22% 6.81% 7.30% 8.36% ROE 5.42% 8.48% 13.44% 11.88% 11.83% ROCE 7.42% 8.95% 12.09% 13.16% 14.79% Fixed Asset Turnover 0.45 0.49 0.79 1.12 1.05 Receivable days 51.16 49.62 37.80 39.70 36.22 Inventory Days 51.33 40.48 42.53 51.30 48.09 Payable days 116.77 140.43 123.30 90.05 46.13 Cash Conversion Cycle -14.29 -50.33 -42.97 0.95 38.18 Total Debt/Equity 0.31 0.69 0.73 0.43 0.20 Interest Cover 3.09 3.85 7.51 6.30 6.41

Top Investors:

tata capital healthcare fund ii

hbm healthcare investments (cayman) ltd

cobra india (mauritius) limited

subhash phootarmal rathod

hi-tech chemicals limited

Annual Reports:

News Update:

Sakar Healthcare - Quarterly Results
8th Feb 2025, 12:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback